B. Hargadon

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
B Hargadon, B. Hargadon, Bev Hargadon, Beverley Hargadon
Publication record
95 papers · 11,155 citations · H-index 36

PAPERS

Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.
202437 citationsauthor #891
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
202421 citationsauthor #2885
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
202467 citationsauthor #407
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
202335 citationsauthor #828
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
202324 citationsauthor #387
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
202319 citationsauthor #388
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
202311 citationsauthor #2796
Relative abundance of Haemophilus as a component of the respiratory microbiome is not associated with airway epithelial MUC5AC staining
20230 citationsauthor #6
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
202395 citationsauthor #2953
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
202322 citationsauthor #460
The effects of inhaled corticosteroids on healthy airways
202311 citationsauthor #8
Visualisation of exhaled breath metabolites reveals distinct diagnostic signatures for acute cardiorespiratory breathlessness
202238 citationsauthor #9
Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker‐high and ‐low severe asthma
202223 citationsauthor #4
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022246 citationsauthor #2901
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
202214 citationsauthor #133
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
2022283 citationsauthor #399
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
202281 citationsauthor #776
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
202235 citationsauthor #2298
Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography–mass spectrometry
202188 citationsauthor #7
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.
2021466 citationsauthor #314
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021142 citationsauthor #2630
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
20211,603 citationsauthor #2312
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021269 citationsauthor #1968
A feasibility study of a randomised controlled trial of asthma-tailored pulmonary rehabilitation compared with usual care in adults with severe asthma.
202023 citationsauthor #6
Volatile organic compounds in a headspace sampling system and asthmatics sputum samples
20207 citationsauthor #7
Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
202084 citationsauthor #39
Lung Computational Models and the Role of the Small Airways in Asthma.
2019101 citationsauthor #7
OP-IJEJ190076_cohort 678..689
20190 citationsauthor #13
Assessment of breath volatile organic compounds in acute cardiorespiratory breathlessness: a protocol describing a prospective real-world observational study
201933 citationsauthor #23
Corrigendum to: Cohort profile: Extended Cohort for E-health, Environment and DNA (EXCEED)
20195 citationsauthor #13
Cohort Profile Cohort Profile : Extended Cohort for E-health , Environment and DNA ( EXCEED )
201918 citationsauthor #12
Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum
201934 citationsauthor #4
Exacerbations of severe asthma in patients treated with mepolizumab
201822 citationsauthor #7
Airway pathological heterogeneity in asthma: Visualization of disease microclusters using topological data analysis
201837 citationsauthor #9
The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma
20178 citationsauthor #3
A CEACAM6-High Airway Neutrophil Phenotype and CEACAM6-High Epithelial Cells Are Features of Severe Asthma
201733 citationsauthor #11
The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma
20178 citationsauthor #4
Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation
201723 citationsauthor #7
P131 Outdoor fungal spore levels, lung function and symptoms in patients with asthma and aspergillus sensitisation
20160 citationsauthor #5
Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography
201659 citationsauthor #9
CEACAM6-high airway neutrophils and epithelial cells are a feature of severe asthma
20151 citationsauthor #10
S7 Airway Pathological Phenotypes and their Clinical Utility in Adult Asthma
20151 citationsauthor #7
TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma
2015435 citationsauthor #12
Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study
201411 citationsauthor #3
Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).
201492 citationsauthor #4
Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma.
201473 citationsauthor #3
Small airways obstruction and asthma exacerbations
20140 citationsauthor #4
COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
201486 citationsauthor #5
Mutually exclusive Th2 and Th17 bronchial gene expression signatures are associated with eosinophilia in asthma
20146 citationsauthor #9
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
2014169 citationsauthor #4
Isolation of Aspergillus fumigatus from sputum is associated with elevated airborne levels in homes of patients with asthma.
201333 citationsauthor #4
S90 Effectiveness of Voriconazole In the Treatment of Aspergillus fumigatus Associated Asthma
20132 citationsauthor #4
Airway dysfunction and inflammation in pool- and non-pool-based elite athletes.
201224 citationsauthor #3
Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.
20124 citationsauthor #4
Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma.
2012310 citationsauthor #6
A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma.
201247 citationsauthor #5
Front & Back Matter
20120 citationsauthor #74
Can We Identify Asthma Patients Who Can Safely Reduce Their Inhaled Corticosteroid Medication Without Suffering From A Loss Of Control
20120 citationsauthor #2
Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1
201297 citationsauthor #6
Podium # 6 Exhaled Nitric Oxide is a Good , Non-Invasive Test for Steroid Responsive Airways Disease in Elite Swimmers
20120 citationsauthor #11
Does Exhaled Nitric Oxide (FENO) Reflect Airway Inflammation In Mild To Moderate Asthma
20120 citationsauthor #2
Profiling of Sputum Inflammatory Mediators in Asthma and Chronic Obstructive Pulmonary Disease
2011150 citationsauthor #6
P20 The eligibility of patients with difficult asthma for omalizumab since the change to the treatment criteria
20103 citationsauthor #2
AIRWAY DYSFUNCTION AND INFLAMMATION IN POOL AND NON-POOL BASED ELITE ENDURANCE ATHLETES
20101 citationsauthor #3
IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma.
2010261 citationsauthor #3
Airway dysfunction and inflammation in pool and non-pool based elite international athletes with symptoms suggesting exercise-induced asthma
20101 citationsauthor #3
Body Mass and Fat Mass in Refractory Asthma: An Observational 1 Year Follow-Up Study
201015 citationsauthor #4
P19 Psychosical factors and the morbidity of severe asthma
20100 citationsauthor #2
S133 Eosinophilic airway inflammation is associated with FEV1 decline in severe asthma
20101 citationsauthor #3
P17 Self-reported physical activity levels and attitudes towards a structured exercise programme in adults with difficult asthma
20101 citationsauthor #3
S132 Airway dysfunction and inflammation in pool and non-pool based elite endurance athletes
20100 citationsauthor #3
Mepolizumab and exacerbations of refractory eosinophilic asthma.
20091,027 citationsauthor #3
The relationship between Aspergillus Fumigatus sensitisation and sputum culture
20093 citationsauthor #3
AIRWAYS DYSFUNCTION AND EOSINOPHILIC INFLAMMATION IN ELITE ATHLETES WITH SYMPTOMS SUGGESTING EXERCISE-INDUCED ASTHMA
20091 citationsauthor #3
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
2007473 citationsauthor #5
The effectiveness of a difficult asthma service from the patient's perspective
20070 citationsauthor #1
Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
2007248 citationsauthor #3
Evidence of a role of tumor necrosis factor alpha in refractory asthma.
2006851 citationsauthor #2
Eligibility for treatment with Omalizumab among patients attending the Glenfield Hospital refractory asthma clinic
20061 citationsauthor #1
Vascular remodelling is a feature of asthma and non-asthmatic eosinophilic bronchitis
20064 citationsauthor #6
Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness
200668 citationsauthor #4
Relationship between exhaled nitric oxide and eosinophilic airway inflammation in chronic obstructive pulmonary disease
20060 citationsauthor #3
The effect of levofloxacin on neutrophilic airway inflammation in stable state chronic obstructive pulmonary disease: A randomised, double blind, placebo controlled trial
20053 citationsauthor #5
Sputum eosinophilia in idiopathic pulmonary fibrosis
200534 citationsauthor #4
Detection of an activating c-kit mutation by real-time PCR in patients with anaphylaxis.
200528 citationsauthor #5
Observational study of the natural history of eosinophilic bronchitis
200597 citationsauthor #2
Airway function and markers of airway inflammation in patients with treated hypothyroidism
200545 citationsauthor #5
CHRONIC OBSTRUCTIVE PULMONARY DISEASE Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease
2005344 citationsauthor #3
Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma
2005226 citationsauthor #2
Induced sputum mediator concentrations in COPD
20031 citationsauthor #4
Evidence of distal lung inflammation in adults with refractory asthma
20031 citationsauthor #3
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
20021,771 citationsauthor #4
A placebo controlled comparison of formoterol, montelukast or higher dose of inhaled corticosteroids in subjects with symptomatic asthma despite treatment with low dose inhaled corticosteroids
20026 citationsauthor #4
The cost effectiveness of an asthma management strategy directed at normalising the induced sputum eosinophil count
20020 citationsauthor #4
Visualisation of exhaled breath metabolites reveals distinct Visualisation of exhaled breath metabolites reveals distinct diagnostic signatures for acute cardiorespiratory breathlessness diagnostic signatures for acute cardiorespiratory breathlessness
year unknown0 citationsauthor #9

TIMELINE

2002 1,777 citations

2003 2 citations

2005 777 citations

2006 924 citations

2007 721 citations

2009 1,031 citations

2010 283 citations

2011 150 citations

2012 482 citations

2013 35 citations

2014 437 citations

2015 437 citations

2016 59 citations

2017 64 citations

2018 59 citations

2019 191 citations

2020 114 citations

2021 2,568 citations

2022 720 citations

2023 217 citations

2024 125 citations

Unknown 0 citations

COAUTHOR MAP

CONCEPT FOOTPRINT